1. Home
  2. OUST vs NNNN Comparison

OUST vs NNNN Comparison

Compare OUST & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ouster Inc.

OUST

Ouster Inc.

HOLD

Current Price

$32.63

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$33.65

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OUST
NNNN
Founded
2015
2021
Country
United States
Germany
Employees
N/A
27
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OUST
NNNN
Price
$32.63
$33.65
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$39.25
N/A
AVG Volume (30 Days)
4.3M
12.9K
Earning Date
05-05-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.20
N/A
Revenue Next Year
$37.27
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$10.06
$7.23
52 Week High
$41.65
$55.65

Technical Indicators

Market Signals
Indicator
OUST
NNNN
Relative Strength Index (RSI) 60.98 64.04
Support Level $26.35 $26.31
Resistance Level $36.03 $44.06
Average True Range (ATR) 3.77 2.77
MACD 0.11 0.50
Stochastic Oscillator 73.78 73.84

Price Performance

Historical Comparison
OUST
NNNN

About OUST Ouster Inc.

Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: